Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
van Schoonhoven, Sushilla
Kowol, Christian R.
Funding for this research was provided by:
Austrian Science Fund (P30105)
Fonds of the City of Vienna for Innovative Cancer Research